Indonesia M&A: Healthcare Licensing, KBLI & Underwriting Evidence

01. The Underwriting Problem: Actual Healthcare Operations vs. Registry and Licensing Evidence

The underwriting problem arises when actual healthcare operations cannot be reconciled with the entity’s registered KBLI classifications, OSS records, operating licences, or investment-realization evidence. Until those dependencies are sufficiently evidenced, the financial model cannot reliably credit the affected operating capacity or projected expansion assumptions [1, 2, 3].

The relevant regulatory framework includes the Omnibus Health Law (Law No. 17 of 2023), Risk-Based Business Licensing (OSS-RBA) under BKPM Regulation No. 5/2025, and Ministry of Health regulations, including Permenkes No. 6 of 2026 on Hospitals [1, 2, 3]. When discrepancies between actual clinical activities and registered parameters occur, they may create regulatory exposure, licensing constraints, remediation requirements, or other financial consequences, depending on the applicable regime and the facts established [2, 3]. Furthermore, healthcare transactions intersect with personal-data obligations under the Personal Data Protection Law (PDP Law No. 27/2022), applicable SATUSEHAT interoperability requirements, and Indonesian merger-control rules administered by KPPU [4, 5, 6].

For institutional buyers, unverified licensing records or ambiguous OSS filings represent a critical break in the Evidence Chain. Under AseanPrimer's underwriting methodology, if the target cannot evidence its complete licensing and compliance posture, projected expansion cash flows and normalized EBITDA multiples remain unquantified or blocked until the relevant evidence is sufficiently established.

02. The Healthcare Regulatory Dependency Graph

To systematically underwrite healthcare compliance risk across multi-branch hospital networks and clinical platforms, AseanPrimer deploys a Regulatory and Evidence Dependency Graph. This architecture traces the logical progression from corporate registration through operating licenses, technical data mandates, and merger thresholds to downstream valuation impacts.

The dependency graph flows through the following core analytical nodes:

• KBLI Classification & OSS Alignment: Verifying whether registered 5-digit KBLI codes and NIB entries accurately reflect the target's actual clinical and commercial revenue-generating activities across all regional branches [2].
• Investment Realization & LKPM Evidence: Assessing whether applicable investment plans and realization commitments associated with legacy or active KBLI codes have been properly reported and fulfilled under the OSS-RBA framework [2].
• Hospital & Facility Operating Licences: Extracting valid operational permits (Izin Operasional) and sector-specific healthcare approvals issued by the Ministry of Health or local health agencies under Permenkes No. 6 of 2026 [3].
• PDP Law & SATUSEHAT Evidence: Assessing applicable personal-data processing requirements and, where relevant, DPIA evidence, together with evidence of applicable SATUSEHAT interoperability and reporting obligations [4, 5].
• KPPU Merger Control Applicability: Testing transaction parameters against the applicable Indonesian asset and sales thresholds to assess whether notification requirements are triggered [6].
• Valuation Input & Transaction Allocation: Identifying affected valuation assumptions and potential transaction-allocation pathways where regulatory exposure remains unresolved.

03. Asset-Specific Underwriting Pathways

While the underlying regulatory engine remains constant, the primary financial variable affected by healthcare regulatory exposure changes depending on the asset class or clinical typology under review:

• General Hospitals (Operating Licences → Applicable BPJS Credentialing → Patient Volume → EBITDA): The principal underwriting variable is whether hospital operating licenses and branch classifications support ongoing insurance (BPJS) credentialing, patient admissions, and projected inpatient revenue.
• Specialized Clinics & Ambulatory Networks (KBLI Alignment → Practice Permits → Clinical Capacity → Roll-Up EBITDA): For clinic networks, the relevant financial dependency is the relationship between facility licensing, medical practice permits, and earnings contribution across acquired regional branches.
• Digital Health & Telehealth Platforms (KBLI Alignment → SATUSEHAT → Applicable PDP Requirements → Operating Continuity → Valuation): For tech-enabled healthcare platforms, the affected variable is data processing compliance, interoperability capital expenditure, and operating continuity under applicable health-data requirements.

04. State Engine: Licensing & Compliance Gaps → Valuation Input

Consider an illustrative acquisition of a regional hospital group in Java operating across multiple municipal branches. The transaction financial model projects immediate EBITDA accretion and assumes legacy business licenses are fully transferable without friction.

Reviewing the Virtual Data Room (VDR) reveals active hospital operational permits in the headquarters, but branch-level KBLI alignment records show discrepancies between registered codes and actual service offerings, and independent evidence of regional LKPM realization commitments is missing.

05. Targeted RFIs & Transaction Allocation Pathways

To resolve evidence gaps and support transaction-specific review, the underwriting desk issues targeted requests for information (RFIs) across separate compliance vectors and outlines potential allocation pathways:

Generated RFI #01 — Licensing, KBLI & Investment Realization

Please provide OSS-RBA profile extracts, branch-level hospital and clinic operating permits, entity-level LKPM submission history, and regional investment realization records.

Generated RFI #02 — Healthcare Data & SATUSEHAT Evidence

Please provide documentation supporting applicable personal-data processing requirements, DPIA evidence where relevant, and SATUSEHAT integration and interoperability records.

Generated RFI #03 — KPPU Merger Control Evidence

Please provide relevant Indonesian asset and sales calculation schedules, methodology, group and transaction perimeter details, and supporting financial factbook extracts for merger notification assessment.

Potential transaction-allocation responses may include assessing whether identified licensing discrepancies should be addressed through pre-closing conditions, specific indemnity or escrow mechanisms, price-adjustment considerations, or other allocation pathways, subject to transaction-specific legal and regulatory advice.